Hydase Market Report 2026

Hydase Market Overview

• The Hydase market growth in the historic period has been driven by need for improved injectable drug dispersion, widespread use in anesthesia delivery • Market expansion is supported by increasing injectable drug volumes, expansion of outpatient procedures • Growth Driver: Rising Geriatric Population To Drive Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hydase Market?

Hydase is a pharmaceutical preparation containing hyaluronidase, an enzyme that enhances the absorption and dispersion of injected medications or fluids by breaking down hyaluronic acid in connective tissues. It is commonly used to improve the effectiveness of subcutaneous and intramuscular injections, facilitate the delivery of local anesthetics, and manage conditions such as extravasation of intravenous drugs. The main types of hydase include animal-derived hyaluronidase and synthetic hyaluronidase. Animal-derived hyaluronidase is an enzyme extracted from animal sources, such as bovine or ovine tissues, that breaks down hyaluronic acid in connective tissues. It is distributed through hospitals, specialty clinics, pharmacies, and online pharmacies and is applied for dermatology, chemotherapy, ophthalmology, plastic surgery, and others.

What Is The Hydase Market Growth Forecast?

The growth in the forecast period can be attributed to increasing injectable drug volumes, expansion of outpatient procedures, growth in cosmetic treatments, adoption of synthetic enzymes, rising focus on patient comfort and efficiency. Major trends in the forecast period include enhanced drug delivery applications, growth in subcutaneous injection optimization, rising use in oncology supportive care, expansion in aesthetic and dermatology procedures, preference for synthetic hyaluronidase.

Global Hydase Market Segmentation

1) By Type: Animal-Derived Hyaluronidase, Synthetic Hyaluronidase 2) By Distribution Channel: Hospitals, Specialty Clinics, Pharmacies, Online Pharmacies 3) By Application: Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, Other Applications

What Are The Drivers Of The Hydase Market?

The rising geriatric population is expected to propel the growth of the hydase market going forward. The geriatric population is individuals aged 65 and older, often requiring specialized healthcare and support due to age-related changes. The geriatric population is increasing due to longer life expectancy, advancements in healthcare, and improvements in living conditions, leading to more people living into older age. Hyaluronidase is used in the geriatric population to enhance the absorption and dispersion of subcutaneous fluids or medications, with caution due to potential age-related skin and tissue changes. For instance, in October 2024, according to a World Health Organization report, a Switzerland-based intergovernmental organization, by 2030, 1 in 6 people in the world will be aged 60 years or over. Therefore, the rising geriatric population is driving the growth of the hydase industry. Increasing demand for minimally invasive surgeries is expected to boost the growth of the hydase market going forward. Minimally invasive surgery is a procedure that uses small incisions and specialized instruments, often including a camera, to perform surgery with less damage to the body, leading to quicker recovery and less pain. Minimally invasive surgeries are increasing due to faster recovery, less pain, smaller scars, reduced complications, and advancements in technology. Hydase is used in minimally invasive surgeries to enhance the effectiveness of treatments by dissolving excess tissue or filler, improving precision, and reducing complications. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, increasing demand for minimally invasive surgeries is driving the hydase industry. Increasing demand for aesthetic procedures is expected to propel the growth of the hydase market going forward. Aesthetic procedures are non-surgical treatments designed to enhance, modify, or rejuvenate a person's appearance, often through methods such as injectables, dermal fillers, and skin resurfacing. The increasing demand for aesthetic procedures is driven by growing consumer desire for non-invasive cosmetic enhancements, advancements in treatment technology, and a rising focus on personal appearance and self-care. Hydase is used in aesthetic procedures to dissolve overfilled dermal fillers or correct undesirable results, ensuring more precise and customizable outcomes. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery, a US-based professional organization dedicated to the advancement of aesthetic (cosmetic) plastic surgery, total surgical and non-surgical procedures rose by 3.4% in 2023, reaching 34.9 million. Face and head procedures saw particularly strong growth, surpassing 6.5 million cases and marking a 19.6% year-over-year increase. Therefore, increasing demand for aesthetic procedures will drive the growth of the hydase industry.

Key Players In The Global Hydase Market

Major companies operating in the hydase market are Akorn Inc., PrimaPharm Inc.

Regional Insights

North America was the largest region in the hydase market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Hydase Market?

The hydase market consists of sales of injectable hyaluronidase enzymes, pre-filled syringes, vials, topical hyaluronidase formulations, and hyaluronidase kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hydase Market Report 2026?

The hydase market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hydase industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.